Halldin C - Search Results

1

Development of a novel fluorine-18 labeled deuterated fluororasagiline ([(18)F]fluororasagiline-D2) radioligand for PET studies of monoamino oxidase B (MAO-B).

Nag S, Lehmann L, Kettschau G, Toth M, Heinrich T, Thiele A, Varrone A, Halldin C. Nag S, et al. Among authors: halldin c. Bioorg Med Chem. 2013 Nov 1;21(21):6634-41. doi: 10.1016/j.bmc.2013.08.019. Epub 2013 Aug 15. Bioorg Med Chem. 2013. PMID: 24012376

2

Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors.

Halldin C, Farde L, Högberg T, Mohell N, Hall H, Suhara T, Karlsson P, Nakashima Y, Swahn CG. Halldin C, et al. J Nucl Med. 1995 Jul;36(7):1275-81. J Nucl Med. 1995. PMID: 7790956 Free article.

3

PET-determination of benzodiazepine receptor binding in studies on alcoholism.

Farde L, Pauli S, Litton JE, Halldin C, Neiman J, Sedvall G. Farde L, et al. Among authors: halldin c. EXS. 1994;71:143-53. doi: 10.1007/978-3-0348-7330-7_15. EXS. 1994. PMID: 8032146

4

Preparation of a potential positron emission tomographic radioligand for the dopamine transporter.

Müller L, Halldin C, Foged C, Karlsson P, Hall H, Swahn CG, Suzdak PD, Hohlweg R, Nielsen EB, Farde L. Müller L, et al. Among authors: halldin c. Eur J Nucl Med. 1994 Feb;21(2):131-7. doi: 10.1007/BF00175760. Eur J Nucl Med. 1994. PMID: 8162936

5

Development of 123I-labelled NNC 13-8241 as a radioligand for SPECT visualization of benzodiazepine receptor binding.

Foged C, Halldin C, Hiltunen J, Braestrup C, Thomsen C, Hansen HC, Suhara T, Pauli S, Swahn CG, Karlsson P, Larsson S, Farde L. Foged C, et al. Among authors: halldin c. Nucl Med Biol. 1996 Apr;23(3):201-9. doi: 10.1016/0969-8051(95)02041-1. Nucl Med Biol. 1996. PMID: 8782227

6

In vitro and in vivo characterisation of nor-beta-CIT: a potential radioligand for visualisation of the serotonin transporter in the brain.

Bergström KA, Halldin C, Hall H, Lundkvist C, Ginovart N, Swahn CG, Farde L. Bergström KA, et al. Among authors: halldin c. Eur J Nucl Med. 1997 Jun;24(6):596-601. doi: 10.1007/BF00841395. Eur J Nucl Med. 1997. PMID: 9169564

7

Fluorine-18-labelled NCQ 115, a selective dopamine D-2 receptor ligand. Preparation and positron emission tomography.

Halldin C, Högberg T, Farde L. Halldin C, et al. Nucl Med Biol. 1994 May;21(4):627-31. doi: 10.1016/0969-8051(94)90028-0. Nucl Med Biol. 1994. PMID: 9234320

8

[11C]NNC 22-0215, a metabolically stable dopamine D1 radioligand for PET.

Foged C, Halldin C, Swahn CG, Ginovart N, Karlsson P, Lundkvist C, Farde L. Foged C, et al. Among authors: halldin c. Nucl Med Biol. 1998 Jul;25(5):503-8. doi: 10.1016/s0969-8051(98)00010-9. Nucl Med Biol. 1998. PMID: 9720669

9

Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors.

Halldin C, Foged C, Chou YH, Karlsson P, Swahn CG, Sandell J, Sedvall G, Farde L. Halldin C, et al. J Nucl Med. 1998 Dec;39(12):2061-8. J Nucl Med. 1998. PMID: 9867142 Free article.

10

Carbon-11 epidepride: a suitable radioligand for PET investigation of striatal and extrastriatal dopamine D2 receptors.

Langer O, Halldin C, Dollé F, Swahn CG, Olsson H, Karlsson P, Hall H, Sandell J, Lundkvist C, Vaufrey F, Loc'h C, Crouzel C, Mazière B, Farde L. Langer O, et al. Among authors: halldin c. Nucl Med Biol. 1999 Jul;26(5):509-18. doi: 10.1016/s0969-8051(99)00005-0. Nucl Med Biol. 1999. PMID: 10473189

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

683 results

Search Page

Filters